p. 29 1.2.3.2 Effet anti apoptotique des ? bloquants dans le coeur, Impact des ?1 bloquants sur l'hémodynamique, p.31 ,
The immunopathogenesis of sepsis, Nature, vol.288, issue.6917, pp.885-91, 2002. ,
DOI : 10.1038/nature01023
The Search for Effective Therapy for Sepsis, JAMA, vol.306, issue.23, pp.2614-2619, 2011. ,
DOI : 10.1001/jama.2011.1853
aent of Endotoxin Shock by Beta Adrenergic Blockade, Annals of Surgery, vol.169, issue.1, pp.74-81, 1969. ,
DOI : 10.1097/00000658-196901000-00007
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, SIS International Sepsis Definitions Conference, pp.1250-1256, 2001. ,
DOI : 10.1097/01.CCM.0000050454.01978.3B
The Epidemiology of Sepsis in the United States from 1979 through 2000, New England Journal of Medicine, vol.348, issue.16, pp.1546-54, 2000. ,
DOI : 10.1056/NEJMoa022139
EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units ,
Pathophysiology of Sepsis and Multiple Organ Failure: Pro- versus Anti-Inflammatory Aspects, Contrib Nephrol, vol.144, pp.31-43, 2004. ,
DOI : 10.1159/000078875
The Pathophysiology and Treatment of Sepsis, New England Journal of Medicine, vol.348, issue.2 ,
DOI : 10.1056/NEJMra021333
Septic cardiomyopathy -A not yet discovered cardiomyopathy?, Exp Clin Cardiol, vol.11, issue.3, pp.226-262, 2006. ,
Pathogenetic mechanisms of septic shock, N Engl J Med, vol.328, issue.20, pp.1471-1478, 1993. ,
Mechanisms of sepsis-induced organ dysfunction, Critical Care Medicine, vol.35, issue.10 ,
DOI : 10.1097/01.CCM.0000282072.56245.91
A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance., Journal of Clinical Investigation, vol.76, issue.4, pp.1539-53, 1985. ,
DOI : 10.1172/JCI112135
Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure, Critical Care Medicine, vol.16, issue.11, pp.1117-1137, 1988. ,
DOI : 10.1097/00003246-198811000-00007
??-blockade during sepsis: Inspired or insane?*, Critical Care Medicine, vol.33, issue.10, pp.2433-2437, 2005. ,
DOI : 10.1097/01.CCM.0000182997.07435.72
Caspase Inhibition Prevents Cardiac Dysfunction and Heart Apoptosis in a Rat Model of Sepsis, American Journal of Respiratory and Critical Care Medicine, vol.160, issue.1 ,
DOI : 10.1073/pnas.96.24.13795
Inappropriate Sympathetic Activation at Onset of Septic Shock, American Journal of Respiratory and Critical Care Medicine, vol.17, issue.2, pp.458-65, 1999. ,
DOI : 10.1161/01.CIR.95.6.1449
Dysfonctionnement myocardique et choc septique, m??decine/sciences, vol.20, issue.12, pp.1115-1123, 2004. ,
DOI : 10.1051/medsci/200420121115
URL : http://www.erudit.org/fr/revues/ms/2004-v20-n12-ms837/009873ar.pdf
Profound but Reversible Myocardial Depression in Patients with Septic Shock, Annals of Internal Medicine, vol.100, issue.4, pp.483-90, 1984. ,
DOI : 10.7326/0003-4819-100-4-483
Myocardial Dysfunction in Severe Sepsis and Septic Shock: More Questions Than Answers?, Journal of Cardiothoracic and Vascular Anesthesia, vol.25, issue.3, pp.526-561, 2011. ,
DOI : 10.1053/j.jvca.2010.11.026
Response of Critically III Patients to Treatment Aimed at Achieving Supranormal Oxygen Delivery and Consumption, Chest, vol.103, issue.3, pp.886-95, 1993. ,
DOI : 10.1378/chest.103.3.886
Modulation of beta-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action ,
Thermal injury and sepsis modulates ??-adrenergic receptors and cAMP reponses in monocyte-committed bone marrow cells, Journal of Neuroimmunology, vol.165, issue.1-2, pp.129-167, 2005. ,
DOI : 10.1016/j.jneuroim.2005.04.015
Turning off the signal: desensitization of beta-adrenergic receptor function., The FASEB Journal, vol.4, issue.11, pp.2881-2890, 1990. ,
DOI : 10.1096/fasebj.4.11.2165947
Impaired ??-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock, Critical Care Medicine, vol.21, issue.1, pp.31-40, 1993. ,
DOI : 10.1097/00003246-199301000-00010
Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock, Critical Care, vol.12, issue.2 ,
DOI : 10.1186/cc6814
Infusion of the ??-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats*, Critical Care Medicine, vol.33, issue.10, pp.2294-301, 2005. ,
DOI : 10.1097/01.CCM.0000182796.11329.3B
Hemodynamic and metabolic effects of selective ??1 adrenergic blockade during sepsis, Surgery, vol.139, issue.5, pp.686-94, 2006. ,
DOI : 10.1016/j.surg.2005.10.010
INCREASED AEROBIC GLYCOLYSIS THROUGH ??2 STIMULATION IS A COMMON MECHANISM INVOLVED IN LACTATE FORMATION DURING SHOCK STATES, Shock, vol.30, issue.4, pp.417-438, 2008. ,
DOI : 10.1097/SHK.0b013e318167378f
Immunodesign of experimental sepsis by cecal ligation and puncture, Nature Protocols, vol.22, issue.1, pp.31-37, 2008. ,
DOI : 10.1164/ajrccm.164.5.2010073
Load Independence of the Instantaneous Pressure-Volume Ratio of the Canine Left Ventricle and Effects of Epinephrine and Heart Rate on the Ratio, Circulation Research, vol.32, issue.3, pp.314-336, 1973. ,
DOI : 10.1161/01.RES.32.3.314
Gleichzeitiger Einsatz von b-1-Rezeptor Blockern und Noradrenalin bei Patienten mit septischem Schock, Wiener klinische Wochenschrift, vol.38, issue.10 ,
DOI : 10.1097/CCM.0b013e3181f204ca
Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock, Intensive Care Medicine, vol.371, issue.8, pp.1344-51, 2011. ,
DOI : 10.1016/S0140-6736(08)60601-7
Elevation of Systemic Oxygen Delivery in the Treatment of Critically Ill Patients, New England Journal of Medicine, vol.330, issue.24, pp.1717-1739, 1994. ,
DOI : 10.1056/NEJM199406163302404
Ejection Fraction Revisited, Anesthesiology, vol.74, issue.1 ,
DOI : 10.1097/00000542-199101000-00026
Septic cardiomyopathy, Annals of Intensive Care, vol.1, issue.1, p.6, 2011. ,
DOI : 10.1186/cc9207
Cardioprotection, attenuated systemic inflammation, and survival benefit of ??1-adrenoceptor blockade in severe sepsis in rats*, Critical Care Medicine, vol.38, issue.2, pp.388-94, 2010. ,
DOI : 10.1097/CCM.0b013e3181c03dfa
Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness., Proceedings of the National Academy of Sciences, vol.86, issue.17, pp.6753-6760, 1989. ,
DOI : 10.1073/pnas.86.17.6753
URL : http://www.pnas.org/content/86/17/6753.full.pdf
Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum, Journal of Experimental Medicine, vol.183, issue.3, pp.949-58, 1996. ,
DOI : 10.1084/jem.183.3.949
Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function, Critical Care Medicine, vol.27, issue.7, pp.1309-1327, 1999. ,
DOI : 10.1097/00003246-199907000-00018
Pro??? versus Anti???inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic Options, The Journal of Infectious Diseases, vol.181, issue.1, pp.176-80, 2000. ,
DOI : 10.1086/315214
Evidence of myocardial hibernation in the septic heart*, Critical Care Medicine, vol.33, issue.12, pp.2752-2758, 2005. ,
DOI : 10.1097/01.CCM.0000189943.60945.77
Bench-to-bedside review: Cytopathic hypoxia, Critical Care, vol.6, issue.6, pp.491-500, 2002. ,
DOI : 10.1186/cc1824
Effects of selective and non-selective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing., Heart, vol.40, issue.8, pp.856-63, 1978. ,
DOI : 10.1136/hrt.40.8.856